Arion Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.3M

  • Investors
  • 1

Arion Bio General Information

Description

Developer of a data-connected and diagnostic platform designed to accelerate the digital transformation of healthcare delivery. The company offers a platform that mechanically interprets test results, a mobile application that presents test instructions and results, and a device intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in the anterior nasal, enabling professionals with home testing technology and high-precision instruments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7041 Koll Center Parkway Unit 280
  • Pleasanton, CA 94588
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 7041 Koll Center Parkway Unit 280
  • Pleasanton, CA 94588
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arion Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Oct-2021 $2.3M Completed Generating Revenue
To view Arion Bio’s complete valuation and funding history, request access »

Arion Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pre-A
To view Arion Bio’s complete cap table history, request access »

Arion Bio Patents

Arion Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11719622-B2 Apparatus for quickly displaying coronavirus test result Active 13-Oct-2020
US-20220113245-A1 Apparatus for quickly displaying coronavirus test result Active 13-Oct-2020
US-20230160444-A1 Apparatus for quickly displaying coronavirus test result Inactive 13-Oct-2020 G01N21/645

Arion Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arion Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
NHH Ventures Corporate Venture Capital Minority
To view Arion Bio’s complete investors history, request access »

Arion Bio FAQs

  • When was Arion Bio founded?

    Arion Bio was founded in 2020.

  • Where is Arion Bio headquartered?

    Arion Bio is headquartered in Pleasanton, CA.

  • What is the size of Arion Bio?

    Arion Bio has 2 total employees.

  • What industry is Arion Bio in?

    Arion Bio’s primary industry is Diagnostic Equipment.

  • Is Arion Bio a private or public company?

    Arion Bio is a Private company.

  • What is the current valuation of Arion Bio?

    The current valuation of Arion Bio is .

  • What is Arion Bio’s current revenue?

    The current revenue for Arion Bio is .

  • How much funding has Arion Bio raised over time?

    Arion Bio has raised $2.3M.

  • Who are Arion Bio’s investors?

    NHH Ventures has invested in Arion Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process